Cargando…

Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles

Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commerci...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrastina, Dace, Petrovskis, Ivars, Lieknina, Ilva, Bogans, Janis, Renhofa, Regina, Ose, Velta, Dishlers, Andris, Dekhtyar, Yuri, Pumpens, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250084/
https://www.ncbi.nlm.nih.gov/pubmed/25436773
http://dx.doi.org/10.1371/journal.pone.0114006
_version_ 1782346948482695168
author Skrastina, Dace
Petrovskis, Ivars
Lieknina, Ilva
Bogans, Janis
Renhofa, Regina
Ose, Velta
Dishlers, Andris
Dekhtyar, Yuri
Pumpens, Paul
author_facet Skrastina, Dace
Petrovskis, Ivars
Lieknina, Ilva
Bogans, Janis
Renhofa, Regina
Ose, Velta
Dishlers, Andris
Dekhtyar, Yuri
Pumpens, Paul
author_sort Skrastina, Dace
collection PubMed
description Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commercially available Silica nanoparticles (initial particles size of 10–20 nm) with that of aluminium hydroxide, or Alum, as well as that of complete and incomplete Freund's adjuvants for the immunisation of BALB/c mice with virus-like particles (VLPs) formed by recombinant full-length Hepatitis B virus core (HBc) protein. The induction of B-cell and T-cell responses was studied after immunisation. Silica nanoparticles were able to adsorb maximally 40% of the added HBc, whereas the adsorption capacity of Alum exceeded 90% at the same VLPs/adjuvant ratio. Both Silica and Alum formed large complexes with HBc VLPs that sedimented rapidly after formulation, as detected by dynamic light scattering, spectrophotometry, and electron microscopy. Both Silica and Alum augmented the humoral response against HBc VLPs to the high anti-HBc level in the case of intraperitoneal immunisation, whereas in subcutaneous immunisation, the Silica-adjuvanted anti-HBc level even exceeded the level adjuvanted by Alum. The adjuvanting of HBc VLPs by Silica resulted in the same typical IgG2a/IgG1 ratios as in the case of the adjuvanting by Alum. The combination of Silica with monophosphoryl lipid A (MPL) led to the same enhancement of the HBc-specific T-cell induction as in the case of the Alum and MPL combination. These findings demonstrate that Silica is not a weaker putative adjuvant than Alum for induction of B-cell and T-cell responses against recombinant HBc VLPs. This finding may have an essential impact on the development of the set of Silica-adjuvanted vaccines based on a long list of HBc-derived virus-like particles as the biological component.
format Online
Article
Text
id pubmed-4250084
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42500842014-12-05 Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles Skrastina, Dace Petrovskis, Ivars Lieknina, Ilva Bogans, Janis Renhofa, Regina Ose, Velta Dishlers, Andris Dekhtyar, Yuri Pumpens, Paul PLoS One Research Article Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commercially available Silica nanoparticles (initial particles size of 10–20 nm) with that of aluminium hydroxide, or Alum, as well as that of complete and incomplete Freund's adjuvants for the immunisation of BALB/c mice with virus-like particles (VLPs) formed by recombinant full-length Hepatitis B virus core (HBc) protein. The induction of B-cell and T-cell responses was studied after immunisation. Silica nanoparticles were able to adsorb maximally 40% of the added HBc, whereas the adsorption capacity of Alum exceeded 90% at the same VLPs/adjuvant ratio. Both Silica and Alum formed large complexes with HBc VLPs that sedimented rapidly after formulation, as detected by dynamic light scattering, spectrophotometry, and electron microscopy. Both Silica and Alum augmented the humoral response against HBc VLPs to the high anti-HBc level in the case of intraperitoneal immunisation, whereas in subcutaneous immunisation, the Silica-adjuvanted anti-HBc level even exceeded the level adjuvanted by Alum. The adjuvanting of HBc VLPs by Silica resulted in the same typical IgG2a/IgG1 ratios as in the case of the adjuvanting by Alum. The combination of Silica with monophosphoryl lipid A (MPL) led to the same enhancement of the HBc-specific T-cell induction as in the case of the Alum and MPL combination. These findings demonstrate that Silica is not a weaker putative adjuvant than Alum for induction of B-cell and T-cell responses against recombinant HBc VLPs. This finding may have an essential impact on the development of the set of Silica-adjuvanted vaccines based on a long list of HBc-derived virus-like particles as the biological component. Public Library of Science 2014-12-01 /pmc/articles/PMC4250084/ /pubmed/25436773 http://dx.doi.org/10.1371/journal.pone.0114006 Text en © 2014 Skrastina et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Skrastina, Dace
Petrovskis, Ivars
Lieknina, Ilva
Bogans, Janis
Renhofa, Regina
Ose, Velta
Dishlers, Andris
Dekhtyar, Yuri
Pumpens, Paul
Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title_full Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title_fullStr Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title_full_unstemmed Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title_short Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
title_sort silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis b core virus-like particles
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250084/
https://www.ncbi.nlm.nih.gov/pubmed/25436773
http://dx.doi.org/10.1371/journal.pone.0114006
work_keys_str_mv AT skrastinadace silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT petrovskisivars silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT liekninailva silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT bogansjanis silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT renhofaregina silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT osevelta silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT dishlersandris silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT dekhtyaryuri silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles
AT pumpenspaul silicananoparticlesastheadjuvantfortheimmunisationofmiceusinghepatitisbcoreviruslikeparticles